Profile data is unavailable for this security.
About the company
Pro Medicus Limited is an Australia-based healthcare informatics company. It provides a full range of medical imaging software and services to hospitals, imaging centers and health care groups in Australia, North America and Europe. Its products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Visage RIS is a radiology information systems (RIS) medical software for practicing of management, training, installation and professional services. Visage RIS capabilities include patient registration, billing, scheduling, typing, HL7 integration, financial reporting, digital dictation and voice recognition integration. Visage 7.0 is a healthcare imaging software that provides clinicians with visualization capability for rapidly viewing two-Dimensional (2-D), 3-D and 4-D medical images and picture archive and communication system (PACS)/digital imaging software that is sold directly and to original equipment manufacturers, training, installation and others.
- Revenue in AUD (TTM)248.69m
- Net income in AUD234.70m
- Incorporated1983
- Employees132.00
- LocationPro Medicus LtdRichmond, 450 Swan StRICHMOND 3121AustraliaAUS
- Phone+61 39429-8800
- Fax+61 39429-9455
- Websitehttps://www.promed.com.au/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASAHI INTECC CO., LTD. | 875.54m | 89.61m | 6.39bn | 9.47k | 71.91 | -- | 41.11 | 7.29 | 36.16 | 36.16 | -- | -- | -- | -- | -- | 9,985,432.00 | -- | 8.09 | -- | 9.51 | 68.85 | 66.02 | 10.28 | 13.78 | -- | 33.10 | -- | 35.60 | 11.60 | 16.24 | -19.43 | 6.77 | -2.47 | 22.43 |
| APT Medical Inc | 492.73m | 157.19m | 6.71bn | 2.56k | 42.55 | 10.97 | -- | 13.61 | 5.46 | 5.46 | 17.14 | 21.20 | 0.7689 | 1.56 | 35.44 | 942,626.30 | 23.97 | 19.84 | 27.54 | 24.22 | 71.50 | 70.81 | 31.18 | 29.16 | 4.11 | -- | 0.0072 | 27.21 | 25.18 | 38.60 | 26.08 | 52.14 | 57.28 | -- |
| Sysmex Corp | 4.66bn | 414.19m | 7.58bn | 10.53k | 18.12 | 1.62 | 9.12 | 1.63 | 71.78 | 71.78 | 806.72 | 803.69 | 0.7448 | 2.54 | 3.21 | 47,749,460.00 | 6.60 | 8.70 | 7.95 | 10.94 | 51.85 | 52.47 | 8.87 | 10.98 | 2.44 | 18.05 | 0.1241 | 38.11 | 10.21 | 10.99 | 8.12 | 9.00 | 13.54 | 5.92 |
| Insilico Medicine Cayman TopCo | 75.76m | -62.67m | 7.60bn | -- | -- | -- | -- | 100.29 | -0.6218 | -0.6218 | 0.7516 | -9.55 | -- | -- | -- | -- | -- | -- | -- | -- | 83.56 | -- | -82.72 | -- | -- | -- | -- | -- | 67.71 | -- | 91.92 | -- | -- | -- |
| XtalPi Holdings Ltd | 139.46m | -40.31m | 8.72bn | 1.05k | -- | 5.69 | -- | 62.56 | -0.0677 | -0.0677 | 0.2148 | 1.97 | 0.1118 | -- | 2.45 | 953,221.80 | -3.31 | -- | -3.58 | -- | 63.91 | -- | -29.62 | -- | 9.65 | -- | 0.0495 | -- | 52.75 | -- | 20.78 | -- | -- | -- |
| Pro Medicus Ltd | 248.69m | 234.70m | 12.35bn | 132.00 | 52.72 | 31.76 | 50.95 | 49.66 | 2.24 | 2.24 | 2.38 | 3.72 | 0.6006 | 4.12 | 3.77 | 1,884,015.00 | 56.68 | 34.81 | 63.01 | 40.65 | 99.87 | 99.69 | 94.37 | 49.37 | 6.22 | -- | 0.0065 | 43.48 | 32.59 | 31.08 | 39.16 | 37.93 | -1.29 | 35.59 |
| Cochlear Ltd | 2.34bn | 345.30m | 13.03bn | 5.50k | 37.83 | 6.72 | 29.38 | 5.57 | 5.27 | 5.27 | 35.67 | 29.64 | 0.8382 | 1.24 | 4.87 | 425,181.80 | 12.38 | 12.88 | 15.71 | 16.53 | 72.76 | 74.26 | 14.77 | 17.20 | 1.44 | 35.20 | 0.1111 | 68.10 | 4.81 | 12.15 | 9.00 | -- | -4.70 | 21.86 |
| Lenskart Solutions Ltd | 1.25bn | 80.39m | 13.54bn | -- | 167.16 | -- | 63.60 | 10.81 | 3.00 | 3.00 | 46.89 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 67.93 | -- | 6.45 | -- | -- | 3.63 | -- | -- | 22.57 | -- | 3,028.30 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 04 Feb 2026 | 2.03m | 1.94% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 1.20m | 1.15% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 1.04m | 0.99% |
| Vanguard Investments Australia Ltd.as of 31 Dec 2025 | 983.36k | 0.94% |
| Geode Capital Management LLCas of 12 Feb 2026 | 684.86k | 0.66% |
| BetaShares Capital Ltd.as of 30 Jan 2026 | 629.32k | 0.60% |
| Brown Capital Management LLCas of 30 Sep 2025 | 500.81k | 0.48% |
| DFA Australia Ltd.as of 31 Dec 2025 | 468.74k | 0.45% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 402.93k | 0.39% |
| BlackRock Advisors (UK) Ltd.as of 06 Feb 2026 | 399.16k | 0.38% |
